Home » Authors » Amanda Pedersen

Articles by Amanda Pedersen

AngioDynamics’ UniBlate adjusts to ablate lesions of varying sizes

Aug. 22, 2007

By Amanda Pedersen

Study: endoscopy found safe for gastric bypass complication

Aug. 20, 2007

By Amanda Pedersen

Philips to acquire Ximis as part of its Healthcare Informatics group

Aug. 17, 2007

By Amanda Pedersen

Failure of preventive service use translates to 100,000 lives lost

Aug. 16, 2007

By Amanda Pedersen

Blood test may offer alternative to that dreaded colonoscopy

Aug. 16, 2007

By Amanda Pedersen

RTI report aims to prevent fraud, boost EHR system efficiency

Aug. 16, 2007

By Amanda Pedersen

Ness L300 for stroke victims a big ‘step’ in right direction

Aug. 15, 2007

By Amanda Pedersen

New heart treatment guidelines for high- vs. low-risk patients

Aug. 14, 2007

By Amanda Pedersen

Failure of preventive service use translates to 100,000 lives lost

Aug. 9, 2007

By Amanda Pedersen

Aetna and NYU kick off P4P pilot; Global Med, FBC, in software pact

Aug. 8, 2007

By Amanda Pedersen

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...